Page last updated: 2024-08-25

tyrosyltyrosine and Anxiety

tyrosyltyrosine has been researched along with Anxiety in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acosta, A; Burton, D; Camilleri, M; Eckert, D; Iturrino, J; O'Neill, J; Shin, A; Vazquez-Roque, MI; Zinsmeister, AR	1

Trials

1 trial(s) available for tyrosyltyrosine and Anxiety

Article	Year
Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology, 2015, Volume: 148, Issue:3 Topics: Adult; Aged; Anti-Obesity Agents; Anxiety; Body Image; Body Mass Index; Cholecystokinin; Cohort Studies; Delayed-Action Preparations; Depression; Dipeptides; Drug Combinations; Fasting; Female; Fructose; Gastric Emptying; Ghrelin; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Obesity; Organ Size; Overweight; Peptide YY; Phentermine; Postprandial Period; Principal Component Analysis; Prospective Studies; Satiation; Self Efficacy; Stomach; Topiramate; Treatment Outcome	2015

Article

Year

Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.

Gastroenterology, 2015, Volume: 148, Issue:3

Topics: Adult; Aged; Anti-Obesity Agents; Anxiety; Body Image; Body Mass Index; Cholecystokinin; Cohort Studies; Delayed-Action Preparations; Depression; Dipeptides; Drug Combinations; Fasting; Female; Fructose; Gastric Emptying; Ghrelin; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Obesity; Organ Size; Overweight; Peptide YY; Phentermine; Postprandial Period; Principal Component Analysis; Prospective Studies; Satiation; Self Efficacy; Stomach; Topiramate; Treatment Outcome

2015